Backed by data from the phase 3 SatraGO trials, satralizumab has the potential to offer patients a convenient, at-home treatment option.
Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instruction can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results